Finance

Lists
900120:KOSDAQ
CXI Healthcare Technology Group Ltd
₩2,810.00
+0.18%
(+5.00) 1D
Nov 18, 11:19:25 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 900120...
Open
₩2,835
High
₩2,835
Low
₩2,780
Mkt. cap
32.81B
Avg. vol.
19.85K
Volume
677.00
P/E ratio
0.48
52-wk high
₩17,900
52-wk low
₩1,955
EPS
₩5,857
Shares outstanding
11.33M
No. of employees
26
Open
₩2,835
High
₩2,835
Low
₩2,780
Mkt. cap
32.81B
Avg. vol.
19.85K
Volume
677.00
P/E ratio
0.48
52-wk high
₩17,900
52-wk low
₩1,955
EPS
₩5,857
Shares outstanding
11.33M
No. of employees
26
News stories
From web sources and news partners
ING Sprinters
ING Sprinters
·
7 hours ago
De AEX Index breekt steun
ZeelandNet, startpagina van Zeeland
ZeelandNet, startpagina van Zeeland
·
8 hours ago
AEX-index lager, chipbedrijven dalen in aanloop cijfers Nvidia
About CXI Healthcare Technology Group Ltd
CEO-
Employees26
Founded2009
Headquarters-
SectorConsumer Staples
IndustryPersonal care products
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
16.75B
7.87B
7.52B
17.33B
Cost of goods sold
10.07B
9.56B
8.20B
9.88B
Cost of revenue
10.07B
9.56B
8.20B
9.88B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.79B
2.28B
1.80B
2.96B
Operating expense
1.73B
1.98B
1.82B
3.25B
Total operating expenses
11.80B
11.54B
10.02B
13.13B
Operating income
4.95B
-3.66B
-2.50B
4.20B
Other non operating income
-168.00K
-424.00K
20.34M
-751.00K
EBT including unusual items
4.86B
-3.74B
-2.71B
9.93B
EBT excluding unusual items
4.87B
-3.76B
-2.65B
3.87B
Income tax expense
-
-
-
269.82M
Effective tax rate
-
-
-
2.72%
Other operating expenses
3.93M
6.17M
2.69M
4.85M
Net income
4.86B
-3.74B
-2.71B
9.66B
Net profit margin
29.03%
-47.57%
-36.03%
55.72%
Earnings per share
-
-
-
-
Interest and investment income
28.31M
27.57M
14.79M
7.22M
Interest expense
-1.80M
-1.80M
-1.66M
-1.76M
Net interest expenses
26.51M
25.78M
13.12M
5.46M
Depreciation and amortization charges
23.00M
23.94M
23.47M
25.51M
EBITDA
11.02B
3.53B
5.67B
13.16B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps